- History of Bleeding and Safety of Abelacimab vs. Rivaroxaban in Atrial Fibrillation:A Secondary Analysis of AZALEA-TIMI 71
-
Moderated Digital Poster 3‚ Clinical Science Zone 1MDP1489
Mahmoud Shams, Brigham and Women's Hosp, Boston, MA; Robert Giugliano, TIMI Study Group, Boston, MA; David Morrow, Erica Goodrich, Brigham and Women's Hosp, Boston, MA; Sanobar Parkar, 444 Warren Street, Jersey City, NJ; Shih-Ann Chen, Taichung Veterans General Hosp, Taichung, Taiwan; Shaun G Goodman, Univ of Toronto, Toronto, ON, Canada; BOYOUNG JOUNG, Yonsei Univ, Seoul, Korea, Republic of; Robert Gabor Kiss, Medical Ctr Hungarian Defence Fo, Budapest, Hungary; Wojtek Wojakowski, Medical Univ of Silesia, Katowice, Poland; Jeffrey Weitz, Thrombosis & Atherosclerosis Res Inst, Hamilton, ON, Canada; Marc S Sabatine, Brigham and Womens Hosp, Boston, MA; Christian Ruff, Brigham and Women's Hosp, Boston, MA; Siddharth M Patel, Brigham and Womens Hosp, Boston, MAGeneric 'disconnected' MessageCommunitiesNavigationSession TypeOnsite Viewing
Enter Note
Go to previous page in this tab
Session
